Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride use may be linked to rare testicular tumor, but more research needed.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Baldness score can't be used to predict prostate size.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

As women age, hair follicles decrease in number and hair width tends to reduce.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

PSA can help diagnose high androgen levels in women.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Finasteride for hair loss may cause depression, affecting sleep and relationships.